FibroBiologics, Inc. Common StockFBLGNASDAQ

Revenue (LTM)

Net Income (LTM)

$-19M

-67.1% YoY

Free Cash Flow

$-17M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	-1
Operating Income	-2	-4↓183.1%	-9↓99.0%	-14↓54.5%	-17↓21.2%
Net Income	-2	-5↓223.7%	-16↓221.9%	-11↑32.3%	-19↓67.1%
EBITDA	-2	-4↓177.1%	-16↓263.6%	-11↑33.5%	-18↓66.6%
EPS Diluted	-0.05	-0.16↓228.5%	-0.59↓268.7%	-0.34↑42.4%	-0.42↓23.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	0	2↑456.8%	9↑304.4%	14↑52.6%	5↓65.0%
Total Current Assets	0	3↑460.9%	9↑251.0%	14↑54.4%	6↓55.4%
Total Assets	0	5↑930.8%	12↑145.0%	16↑39.1%	10↓41.5%
Total Current Liabilities	2	7↑302.3%	9↑29.8%	13↑38.6%	2↓86.2%
Total Liabilities	2	9↑401.7%	11↑19.8%	14↑29.7%	3↓74.7%
Total Equity	-1	-4↓209.8%	1↑131.4%	3↑118.3%	6↑125.1%
Total Debt	1	8↑478.8%	2↓76.8%	11↑504.1%	2↓77.2%
Net Debt	1	5↑488.8%	-7↓241.0%	-3↑53.7%	-2↑27.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-1	-4↓188.4%	-6↓57.4%	-12↓85.9%	-16↓37.8%
Capital Expenditure	0	0	-0	-0↑62.8%	-0↓42.4%
Free Cash Flow	-1	-4↓188.4%	-7↓69.6%	-12↓75.2%	-17↓37.8%
Stock-Based Comp	0	0	2↑566.0%	2↑25.7%	3↑21.0%
Net Change in Cash	0	2↑356.8%	7↑271.0%	5↓30.1%	-9↓288.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance